ORN Summer 2024 - Xylazine Wound Care Clinic and Protocol-Handout

Handout - Xylazine-associated Wound Care

Pdf Summary

The document is a summary of an ORN webinar series focusing on Xylazine-associated wound care. Xylazine, a veterinary sedative, is now being used as a drug of abuse, leading to unique wound care considerations. The Prevention Point Wound Care Clinic in Philadelphia has seen a rise in individuals with Xylazine-associated wounds, presenting challenges like severe tissue damage, biofilm formations, and infections. The clinic follows a harm reduction model, offering low-barrier access to care without co-pays, and collaborating with allied providers for comprehensive support. The standardized D.I.M.E. approach (Debridement, Infection/Inflammation, Moisture, Edges) is highlighted for wound assessment and treatment. Hospital considerations include surgical debridement approaches, skin graft/flap options, and the use of dermal substitutes like BTM for wound management. The document emphasizes the importance of antibiotic stewardship, pain management, and harm reduction strategies in addressing the complex needs of individuals with Xylazine-associated wounds. Education, open communication, and tailored wound care strategies are crucial in optimizing outcomes and promoting healing in this vulnerable population. It also delves into the social and psychological aspects of wound care, striving to provide compassionate and effective care for those affected.

Keywords

Xylazine-associated wounds

wound care

veterinary sedative

harm reduction

Prevention Point Wound Care Clinic

D.I.M.E. approach

surgical debridement

antibiotic stewardship

pain management

biofilm formations